Tag

PDUFA

2 stories

FDA Cleared Filspari for FSGS Despite Phase 3 Fail, Opening $2B Market

FDA cleared Filspari for focal segmental glomerulosclerosis on Monday, making Travere Therapeutics' endothelin blocker the first and only approved drug for…

FDA Apr 5, 2026

Lilly's Oral GLP-1 Pill Cleared in 50 Days, Fastest NME Since 2002

Eli Lilly's oral GLP-1 pill orforglipron approved in 50 days under the FDA's CNPV pilot — the fastest new molecular entity approval since 2002.